ReviewAlzheimer's & dementia (New York, N. Y.)2018

Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials.

Michael Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.